title: Novel autologous T-cell therapy for drug-resistant cytomegalovirus disease after lung transplantation.
authors.affiliation: Lung Transplant Unit, St. Vincent's Hospital, Sydney, New South Wales, Australia.
authors.forename: Paola
authors.initials: P
authors.lastname: Pierucci
authors.affiliation: Lung Transplant Unit, St. Vincent's Hospital, Sydney, New South Wales, Australia.
authors.forename: Monique
authors.initials: M
authors.lastname: Malouf
authors.affiliation: Lung Transplant Unit, St. Vincent's Hospital, Sydney, New South Wales, Australia.
authors.forename: Allan R
authors.initials: AR
authors.lastname: Glanville
authors.affiliation: QIMR Centre for Immunotherapy and Vaccine Development, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
authors.forename: Leone
authors.initials: L
authors.lastname: Beagley
authors.affiliation: QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
authors.forename: Corey
authors.initials: C
authors.lastname: Smith
authors.affiliation: QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
authors.forename: Rajiv
authors.initials: R
authors.lastname: Khanna
mesh_terms: D000998:Antiviral Agents; D064987:Cell- and Tissue-Based Therapy; D003587:Cytomegalovirus; D003586:Cytomegalovirus Infections / Q000628:therapy*; D006801:Humans; D016040:Lung Transplantation; D013601:T-Lymphocytes; D014182:Transplantation, Autologous
chemical_list: D000998:Antiviral Agents